We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Feature

Impax Heads To Rare Trial In Pay-For-Delay Case

Law360 (March 9, 2018, 10:04 PM EST) -- Impax Laboratories Inc. is set to face a Massachusetts jury Monday over allegations it received illegal reverse payments from Medicis Pharmaceutical Corp. to delay a generic form of acne medication Solodyn,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.